Variable expression of parkinson’s disease: A base-line analysis of the datatop cohort

Neurology

Volumn 40, Issue 10, 1990, Pages 1529-1534

  Jankovic, J ^a   McDermott, M ^a   Carter, J ^a   Gauthier, S ^a   Goetz, C ^a   Golbe, L ^a   Huber, S ^a   Koller, W ^a   Olanow, C ^a   Shoulson, I ^a   Stern, M ^a   Tanner, C ^a   Weiner, W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; BRADYKINESIA; CLASSIFICATION; COMPUTER ANALYSIS; DATA BASE; FEMALE; GAIT; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; TREMOR;

ADULT; AGED; COHORT STUDIES; FEMALE; GAIT; HUMAN; MALE; MIDDLE AGE; PARKINSON DISEASE; POSTURE; SEVERITY OF ILLNESS INDEX; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TREMOR;

EID: 0025086894     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.10.1529     Document Type: Article

References (33)

1. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:745–752.
2. Caine DB. Is “Parkinson’s disease” one disease? J Neurol Neurosurg Psychiatry 1989;(Suppl):18–21.
3. Mjones H. Paralysis agitans: a clinical and genetic study. Acta Psychiatr Neurol Scand 1949;25(Suppl 54):1–195.
4. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427–442.
5. Scott RM, Brody JA. Benign early onset of Parkinson’s disease: a syndrome distinct from classical postencephalitic parkinsonism. Neurology 1971;21:366–368.
6. Birkmayer W, Reiderer P, Youdim JBH. Distinction between benign and malignant type of Parkinson’s disease. Clin Neurol Neurosurg 1979;81:158–164.
7. Mortimer JA, Pirozzolo FJ, Hansch EC, Webster DD. Relationship of motor symptoms to intellectual deficits in Parkinson’s disease. Neurology 1982;32:133–137.
8. Roy M, Boyer L, Barbeau A. A prospective study of 50 cases of familial Parkinson’s disease. Can J Neurol Sci 1983;10:37–42.
9. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology 1985;35:522–526.
10. Santamaria J, Tolosa E, Valles A. Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130–1133.
11. Quinn N, Critchley P, Marsden CD. Young-onset Parkinson’s disease. Mov Disord 1987;2:73–91.
12. Gershanik OS. Parkinsonism of early onset. In: Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders. Baltimore: Urban and Schwarzenberg, 1988:191–204.
13. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson’s disease. Neurology 1988;38:1402–1406.
14. Goetz CG, Tanner CM, Stebbins GT, Buchman AS. Risk factors for progression in Parkinson’s disease. Neurology 1988;38:1841–1844.
15. Hietanen M, Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:244–249.
16. Dubois B, Pillon B, Stemic N, Lhermitte F, Agid Y. Age-induced cognitive disturbances in Parkinson’s disease. Neurology 1990;40:38–41.
17. Huber SJ, Paulson GW, Shuttleworth EC. Relationship of motor symptoms, intellectual impairment, and depression in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:855–858.
18. Diamond SG, Markham CH, Hoehn MM, et al. Effect of age at onset on progression and mortality in Parkinson’s disease. Neurology 1989;39:1187–1190.
19. Starkstein SE, Berthier ML, Bolduc PL, et al. Depression in patients with early versus late onset of Parkinson’s disease. Neurology 1989;39:1441–1445.
20. Parkinson Study Group. DATATOP: a multi-center controlled clinical trial in early Parkinson’s disease. Arch Neurol 1989;46:1052–1060.
21. Parkinson Study Group. Deprenyl forestalls disability in early Parkinson’s disease: a controlled clinical trial. N Engl J Med 1989;321:1364–1371.
22. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Caine D, Goldstein M, eds. Recent developments in Parkinson’s disease, vol 2. Florham Park, NY: MacMillan Healthcare Information, 1987:153–163,293–304.
23. Scherman D, Desnons C, Darchen F, et al. Striatal dopamine deficiency in Parkinson’s disease: role of aging. Ann Neurol 1989;26:551–557.
24. Mayeux R, Stem Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson’s disease. Neurology 1981;31:645–650.
25. Mortimer JA, Pirozzolo FJ, Hansch EC, et al. Relationship of motor symptoms to intellectual deficits in Parkinson’s disease. Neurology 1982;32:133–137.
26. Growdon JH, Corkin S, Desclos G, Rosen TJ. Hoehn and Yahr stages predict the extent of cognitive deficit in Parkinson’s disease. Neurology 1987;37:157.
27. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Besson JAO, Mutch J. Clinical features predicting dementia in idiopathic Parkinson’s disease: a follow-up study. Neurology 1990;40:1222–1224.
28. Mortimer JA, Jun SP, Kuskowski MA, Webster DD. Subtypes of Parkinson’s disease defined by intellectual impairment. J Neural Transm 1987;24(Suppl):101–104.
29. Pillon B, Dubois B, Cusimano G, et al. Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 1989;52:201–206.
30. Zweig RM, Jankel WR, Hedreen JC, et al. The pedunculopontine nucleus in Parkinson’s disease. Ann Neurol 1989;26:41–46.
31. Jankovic J. Essential tremor and Parkinson’s disease. Ann Neurol 1989;25:211.
32. Lang AE, Kierans C, Blair RDG. Family history of tremor in Parkinson’s disease compared with those of controls and patients with idiopathic dystonia. Adv Neurol 1986;45:313–316.
33. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Muenter MD. An examination of male-female differences in progression and mortality of Parkinson’s disease. Neurology 1990;40:763–766.